Group 1 - The Cigna Group is ranked sixth among the best investments during a recession according to a recent compilation [1] - Mizuho analyst Ann Hynes has maintained a Buy rating on Cigna Group (CI) and adjusted the price target to $325 from $307, indicating a positive outlook despite slowing healthcare utilization growth [1] - Cigna Group is a global health services company providing a range of insurance solutions and operates in over 30 countries, focusing on integrated care and pharmacy benefit management [3] Group 2 - Cigna Group is set to release its fourth quarter 2025 financial results on February 5, 2026 [2]

Core Insights - The Cigna Group is valued at a market cap of $80.6 billion and offers a range of health services and insurance solutions, with Q3 earnings announcement scheduled for October 30, 2025 [1] Financial Performance - Analysts expect Cigna to report a profit of $7.70 per share for Q3 2025, reflecting a 2.5% increase from $7.51 per share in the same quarter last year [2] - For the current fiscal year ending in December, Cigna is projected to report a profit of $29.69 per share, an 8.6% increase from $27.33 per share in fiscal 2024, with further growth expected to $32.97 in fiscal 2026 [3] Stock Performance - Cigna's stock has declined 13.4% over the past 52 weeks, underperforming the S&P 500 Index and the Health Care Select Sector SPDR Fund [4] - Despite reporting better-than-expected Q2 results with adjusted revenue of $67.1 billion and adjusted income of $7.20 per share, the stock fell 10.2% post-announcement due to concerns over a 2.1% decline in total customer relationships [5] Analyst Ratings - Wall Street analysts maintain a "Strong Buy" rating for Cigna, with 17 out of 24 analysts recommending "Strong Buy," and a mean price target of $369.90, indicating a potential upside of 22.4% from current levels [6]